main-image-vitae

Vitae Pharmaceuticals

Vitae Pharmaceuticals (NASDAQ: VTAE) is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases.

 

Headquarters Fort Washington, PA
Website www.vitaepharma.com​
Pipeline Multiple candidates from preclinical to Phase 2
Partners Boehringer Ingelheim